Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Critical Diagnostics is a company on the cutting edge of this change, focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases. Their lead product, the Presage® ST2 Assay, has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure patients. Soluble ST2 has now been published in more than 100 peer-reviewed articles and scientific posters studying more than 36,000 patients. These clinical studies have demonstrated that high levels of soluble ST2 are predictive of adverse patient outcomes and death in a broad spectrum of cardiovascular disease. They have further shown that the prognostic information from soluble ST2 is independent and provides added information to the cardiac biomarkers commonly used today, including the natriuretic peptides, BNP and NT-proBNP. Critical Diagnostics was founded in 2004. The Company licensed intellectual property discovered in 2002 at Brigham and Women's Hospital relating to ST2, for which it now holds the exclusive worldwide rights. The company has since expanded its intellectual property portfolio and holds several issued patents in the US and abroad as well as numerous patents pending.

Jurilab Oy provides research and development services. The firm offers pharmacokinetic tests, genotyping services, drug target discovery and Phenotype and target validation services. The company was founded in 1999 and is headquartered in Kuopio, Finland.

Abunda Nutrition, Inc., a subsidiary of Evolva Holding SA, is a company headquartered in San Francisco, CA, that discovers, develops and commercializes next-generation food ingredients and product solutions. Evolva Holding SA acquired Abunda Nutrition, Inc. on July 08, 2011 for $56.98 million.

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. The company applies its pioneering expertise in hypoxia-inducible factor (HIF), connective tissue growth factor (CTGF) biology, and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. FibroGen's product Roxadustat is an oral small-molecule inhibitor of HIF prolyl hydroxylase activity in worldwide Phase 3 clinical development for the treatment of anemia in chronic kidney disease (CKD), with a New Drug Application currently under review in China by the State Drug Administration or SDA (formerly the China Food and Drug Administration).

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Shanxi Huihu Health Technology Co., Ltd., established on 2015-02-05, Business scope includes nutrition and health consultation(Does not contain medical diagnoses);Big data service;cloud computing service;artificial intelligence technology,Technology Development of Network Technology,Technology Promotion,technology transfer,Technical Consulting and Technical Services;Technology development of computer software,Technical Consulting and Technical Services;Computer System Integration Services;Electronic Product Design;Computer hardware and software and consumables,stationery(no publications),sporting goods(without crossbow),Sales of daily necessities;Import and export business;food business:Sales of prepackaged and bulk foods.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kanglu Bio is positioned to provide clinical diagnosis and guidance for clinical drug molecular diagnostic products and clinical molecular diagnostics overall service providers for clinical hospitals and third-party clinical independent testing institutions. The products and services are mainly used in cardiovascular and cerebrovascular diseases. Major diseases such as tumors and cancer.

Wuzheng Intelligent Technology (Beijing) Co., Ltd., established on 2019-12-25, Business scope includes technology development,technology transfer,Technology Promotion,technical consulting;Computer System Services;Basic software service;Application software service;software development;software consulting;design,make,acting,Place an ad;sell edible produce,medical instrumentsIkind,medical instrumentsIIkind,electronic product,software,self-developed product,communication equipment;health management,Health Advisory(Except for medical treatment activities subject to approval);sell food;Internet information service.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Internet information service,Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Genesis Healthcare, Inc. is a holding company, which engages in the provision of specialized healthcare services. It also offers rehabilitation and respiratory therapy services. It operates through the following segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. The Inpatient Services segment manages the operation of skilled nursing facilities and assisted/senior living facilities. The Rehabilitation Therapy Services segment offers speech-language pathology (SLP), physical therapy (PT), occupational therapy (OT), and respiratory therapy services. The Other Services segment consists of physician, staffing, and other healthcare related services. The company was founded in 1985 and is headquartered in Kennett Square, PA.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Huawei Technologies is a telecom solutions company that offers infrastructure application software and devices with wireline, wireless, and IP technologies. The company’s products and solutions have been deployed in over 100 countries and have served 45 of the world's top 50 telecom operators as well as one third of the world's population. Huawei Technologies has 3 divisions in the United States: enterprise (IP networking and routers, wireless, storage, data center security), carrier, and consumer devices (smartphones and tablets). Founded in January 1987, Huawei Technologies is headquartered in Shenzhen, Guangdong. Its testing lab is based in Plano, Texas with an additional office in Santa Clara, California.

Beijing Dongfangxingqi Food Industry Technology Co., Ltd., established on 2001-07-20, Business scope includes technology development,Technology Promotion,Technical Services,technology transfer,technical consulting;health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Medical Research and Experimental Development,Natural science research and experimental development.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Beijing Yisi Medical Equipment Co., Ltd., established on 1995-01-06, Business scope includes sales of medical devices(Subject to the medical device operating enterprise license);Production of Class II medical devices;technology development,technical consulting,Technology Promotion,Technical Services;Sales of machinery and equipment,electronic product,computer,Software and Auxiliary Equipment;Technology Import and Export;Import and export;Agent import and export.(Enterprises independently choose operating projects according to law,Carry out business activities;Production of second-class medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Shenzhen Zhongke Jinzheng Technology Co. Ltd., part of Shanghai United Imaging Healthcare Co., Ltd., is a Chinese company located in Shenzhen that engages in computer software hardware technology development operation. On April 30, 2015 Shanghai United Imaging Healthcare Co., Ltd. acquired Shenzhen Zhongke Jinzheng Technology Co. Ltd.